518 related articles for article (PubMed ID: 14981990)
21. Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma.
Melichar B; Ferko A; Krajina A; Rousková L; Dvorák J; Svébisova H; Neoral C; Köcher M; Malirová E; Paral J
J BUON; 2012; 17(4):677-83. PubMed ID: 23335524
[TBL] [Abstract][Full Text] [Related]
22. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Link KH; Sunelaitis E; Kornmann M; Schatz M; Gansauge F; Leder G; Formentini A; Staib L; Pillasch J; Beger HG
Cancer; 2001 Dec; 92(11):2746-53. PubMed ID: 11753947
[TBL] [Abstract][Full Text] [Related]
23. Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.
Mancuso A; Giuliani R; Accettura C; Palma M; D'Auria G; Cecere F; Paoluzzi L; Bezzi M; Massidda B; Cortesi E
Anticancer Res; 2003; 23(2C):1917-22. PubMed ID: 12820479
[TBL] [Abstract][Full Text] [Related]
24. Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma.
Fazio N; Orsi F; Grasso RF; Ferretti G; Medici M; Rocca A; Zampino G; Curigliano G; De Pas T; Colleoni M; Bonomo G; Marrocco E; Lunghi L; De Braud F
Anticancer Res; 2003; 23(6D):5023-30. PubMed ID: 14981962
[TBL] [Abstract][Full Text] [Related]
25. Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.
Khouri C; Guiu B; Cercueil JP; Chauffert B; Ladoire S; Ghiringhelli F
Anticancer Drugs; 2010 Jul; 21(6):656-61. PubMed ID: 20216061
[TBL] [Abstract][Full Text] [Related]
26. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
[TBL] [Abstract][Full Text] [Related]
27. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
Qin B; Kato K; Mitsugi K; Nakamura M; Tanaka R; Baba E; Ariyama H; Kuroiwa T; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Jan; 57(1):114-9. PubMed ID: 16001177
[TBL] [Abstract][Full Text] [Related]
29. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
30. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
[TBL] [Abstract][Full Text] [Related]
31. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.
Kern W; Beckert B; Lang N; Stemmler J; Beykirch M; Stein J; Goecke E; Waggershauser T; Braess J; Schalhorn A; Hiddemann W
Ann Oncol; 2001 May; 12(5):599-603. PubMed ID: 11432616
[TBL] [Abstract][Full Text] [Related]
32. Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
Al-Batran SE; Kerber A; Atmaca A; Dechow C; Reitsamer E; Schmidt S; Kolassa Y; Neumann A; Weidmann E; Hartmann JT; Jäger E
Onkologie; 2007 Feb; 30(1-2):29-34. PubMed ID: 17264523
[TBL] [Abstract][Full Text] [Related]
33. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
[TBL] [Abstract][Full Text] [Related]
34. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
[TBL] [Abstract][Full Text] [Related]
35. [Switching to direct intrahepatic arterial infusion of 5-FU after a progression of liver metastases from colorectal carcinoma treated with systemic infusion of FOLFOX].
Kikuoka S; Miura T; Takeuchi I; Miura T; Akamatsu N; Ishida F; Ozawa F; Moriguchi M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2036-8. PubMed ID: 20037315
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic adjuvant hepatic arterial infusion chemotherapy reduced hepatic metastases from Stage III colorectal cancer after curative resection.
Feng WM; Tang CW; Huang SX; Zheng YY; Bao Y; Wang Y; Tao YL
Hepatogastroenterology; 2012 Jun; 59(116):1087-90. PubMed ID: 22328287
[TBL] [Abstract][Full Text] [Related]
37. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911
[TBL] [Abstract][Full Text] [Related]
38. [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer].
Arai Y; Endo T; Miyake Y; Sakamoto K; Kido C
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2731-4. PubMed ID: 2782885
[TBL] [Abstract][Full Text] [Related]
39. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
40. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
